newwin
Luciann Nguyen
Settings
← Accounts
academic

Institut du Cancer de Montpellier - Val d'Aurelle

68
Account opportunity
Not established
Relationship
1
Active signals
1
Trials as sponsor

Why this account matters

Institut du Cancer de Montpellier - Val d'Aurelle

New trial — Analysis of Circulating Tumor Markers in Blood

New trialNCT04025541
68/100
Opportunity
Commercial fit23/25
Clinical timing11/20
Biomarker need15/20
Relationship2/10
Signal strength9/10
Account value7/10
Urgency1/5

New not applicable trial NCT04025541 posted by Institut du Cancer de Montpellier - Val d'Aurelle: "Analysis of Circulating Tumor Markers in Blood". New trial on a not applicable recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).

Why nowClinicalTrials.gov record updated 524 days ago.

ConfidenceHigh · 95%clinical development · translational medicine · clinical operations

NextMap clinical development and translational medicine stakeholders on the sponsor, confirm no colleague is mid-conversation, then draft evidence-based outreach.

Trials

TrialPhaseTesting language
NCT04025541
Analysis of Circulating Tumor Markers in Blood
not applicable
mol. elig.ctDNA